聖濟堂(600227.SH)2019年業績由盈轉虧 預虧17億元
格隆匯1月20日丨聖濟堂(600227.SH)發佈2019年年度業績預告,預計2019年年度實現歸屬於上市公司股東的淨利潤與上年同期淨利潤1.99億元相比,將出現虧損,實現歸屬於上市公司股東的淨虧損17億元。歸屬於上市公司股東扣除非經常性損益後的淨虧損17.1億元。
化工業務方面。本次業績預告期間,受產能過剩、下游需求疲軟等不利因素影響,公司主導產品尿素、甲醇的平均銷售價格較去年同期相比有所下降;同時,公司對“煤頭”生產裝置及其相關資產計提了資產減值準備16.49億元,導致公司化工業務淨利潤由盈轉虧。
醫藥業務方面。本次業績預告期間,由於國家積極推進藥品集中帶量採購政策、多個省市實行價格聯動政策及公司藥品一致性評價進展不如預期,使得公司西藥銷售數量和價格同比下降;同時,受中藥材價格上漲、中藥處方政策等因素影響,公司中藥銷售數量和毛利率較去年同期相比有所下降。綜上導致公司醫藥業務淨利潤預計同比下滑1.5億。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.